The Bulletin
Men's Weekly


.

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

  • Written by PR Newswire
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
  • "Aiming to offer a Dengue antiviral treatment course in $100 price range"
  • Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval

SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that, after multiple...